 |
|
Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options
Yun-Jin Lee, Sang Ook Nam, Ara Ko, JuHyun Kong, Shin Yun Byun
Clin Exp Pediatr. 2021;64(3):103-110. Published online 2020 May 14 DOI: https://doi.org/10.3345/cep.2019.01305
|
|
Citations to this article as recorded by
 Can serum C3/C4 complement ratio be used in the differential diagnosis of central nervous system demyelinating diseases?
Melike Cakan, Bariscan Cimen, Nazire Pınar Acar-Ozen, Yildirim Sara, Rana Karabudak, Aslı Tuncer
Multiple Sclerosis and Related Disorders.2025; 95: 106312. CrossRef Myelin oligodendrocyte glycoprotein associated disease
Nikhat Iqbal Tamboli, Asma Farheen, Snehalata Yellambkar, Rajesh Subhash Joshi
Journal of Clinical Ophthalmology and Research.2025; 13(2): 275. CrossRef Quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with AQP4-IgG positive neuromyelitis optica spectrum disorders: A Korean multicenter study
Hyun Ji Lyou, Ha Young Shin, Hye Lim Lee, Young Nam Kwon, Seong-il Oh, Jeeyoung Oh, Eun Bin Cho, Sunyoung Kim, Seol-Hee Baek, Byung-Jo Kim, Eunhee Sohn, Jin Myoung Seok, Ju-Hong Min, Seung Woo Kim, Byoung Joon Kim
Multiple Sclerosis and Related Disorders.2024; 91: 105914. CrossRef Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry
Amanda Marchionatti, Gisele Hansel, Gabriela Urbanski Avila, Douglas Kazutoshi Sato
Frontiers in Immunology.2021;[Epub] CrossRef
|